Latest News

Filters

Filter by tags: Medicine United States Clear all tag filters

7 news articles found


Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Bangladesh is committed to continuous improvement of nuclear and radiation safety, an International Atomic Energy Agency (IAEA) team of experts has concluded. The Integrated Regulatory Review Service (IRRS) mission team identified areas for possible improvements.

Date: Friday, 16 December 2022
Original article: world-nuclear-news.org/Articles/IAEA-says-Bangladesh-committed-to-nuclear-safety

The Australian Nuclear Science and Technology Organisation (ANSTO) and Canada’s Terrestrial Energy have agreed to explore ANSTO Synroc (synthetic rock) proprietary waste treatment technology for used fuel management.

Date: Friday, 04 February 2022
Original article: neimagazine.com/news/newsterrestrial-energy-and-ansto-sign-agreement-for-used-fuel-management-9459924

The nuclear medicine sector is a small part of the wider nuclear industry, but it provides some of the most pioneering technologies in healthcare - and is close to making personalised medicine a reality. Antonis Kalemis, president of Nuclear Medicine Europe and business manager for molecular imaging at Siemens Healthineers, describes how nuclear medicine also tackles the most trenchant condition in modern healthcare: cancer.

Date: Thursday, 29 July 2021
Original article: world-nuclear-news.org/Articles/Viewpoint-Nuclear-medicine-is-crucial-for-fighting

A report from the US National Academy of Sciences argues that the nuclear industry needs to do better than deterministic risk analysis, as embodied by the principle of the design-basis accident, which is designed to prevent certain specified abnormal events. These have been shown over the past 30 years to be inadequate to prevent core-melt accidents and mitigating their consequences. "The Fukushima Daiichi, Three Mile Island, and Chernobyl accidents were all initiated by beyond-design-basis events... a more complete application of modern risk-assessment principles in licensing and regulation could help address this inadequacy and enhance the overall safety of all nuclear plants, present and future."

Date: Monday, 28 July 2014
Original article: neimagazine.com/news/newsbeyond-design-basis-risks-key-to-nuclear-accidents-post-fukushima-report-4328665

The National Academy of Sciences (NAS) is seeking nominations for membership on the “Committee on the Analysis of Cancer Risks in Populations near Nuclear Facilities: Phase 1,” part of a Nuclear Regulatory Commission-sponsored, state-of-the-art study.

Date: Friday, 03 September 2010
Original article: neimagazine.com/news/newsexperts-to-conduct-nrc-sponsored-cancer-risk-study-usa-deadline-30-september-2010